Earnings Releases·Nov 13, 2026, 4:06 PM ET

OptimizeRx — Third Quarter 2026 Earnings Summary

Q3 2026 revenue declined 17% year-over-year to $21.6 million, while GAAP net income rose 50% to $1.2 million and Non-GAAP net income increased 23% to $3.8 million.
Fiscal 2026 revenue guidance was lowered to $87 million–$93 million due to in-year contracted revenue tracking below prior-year levels, though adjusted EBITDA guidance remains unchanged at $21 million–$25 million.
Management anticipates growth in contracted revenue for 2027 driven by a strong RFP season and renewed spending from a significant customer in Q4.
The company reduced outstanding debt principal to $10.4 million by repaying $9.3 million since June 30, 2026, while expanding AI-enabled capabilities through partnerships with DeepIntent, The Trade Desk, and PulsePoint.